EC Number   |
Natural Substrates  |
|---|
   2.4.1.41 | more |
involved in development, necessary for viability |
| 2.4.1.41 | more |
pp-GalNAc-T13 is specifically expressed in neurons and synthesizes Tn antigen |
| 2.4.1.41 | more |
UDP-GalNAc polypeptide:N-acetylgalactosaminyltransferase catalyzes the first step in the mucin-type O-glycan biosynthesis pathway by transferring GalNAc to Ser or Thr residues in a protein from the sugar donor UDP-GalNAc |
| 2.4.1.41 | more |
UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases transfer GalNAc from UDP-GalNAc to the Ser and Thr residues of polypeptide acceptors, and initiate and regulate mucin-type O-glycosylation |
| 2.4.1.41 | more |
no activity with 2'-deoxy-alpha-D-galactosamine or 2'-oxymethyl-alpha-D-galactosamine |
| 2.4.1.41 | UDP-N-acetyl-alpha-D-galactosamine + polypeptide |
- |
| 2.4.1.41 | UDP-N-acetyl-alpha-D-galactosamine + polypeptide EA2 |
sequence PTTDSTTPAPTTK |
| 2.4.1.41 | UDP-N-acetyl-alpha-D-galactosamine + polypeptide Muc1 |
- |
| 2.4.1.41 | UDP-N-acetyl-alpha-D-galactosamine + polypeptide MUC13 |
isoform GALNT14 contributes to the glycosylation of peptide MUC13, which is significantly higher in ovarian cancer cells compared with the normal/benign ovary tissues |
| 2.4.1.41 | UDP-N-acetyl-D-galactosamine + bone sialoprotein |
preferred substrate of isozyme ppGalNAcT-1, glycosylation of Thr101, Ser131, Thr199, and Ser214, glycosylation pattern, overview |
